Literature DB >> 16179484

Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy.

Mizuko Yoshida1, Akira Yonetani, Toshihiro Shirasaki, Keiji Wada.   

Abstract

The mdx mouse is an animal model for Duchenne muscular dystrophy. Mdx mice fed a 12% NaCl diet from birth up to 20 days of age (mdx-Na mice) had an approximately 50% reduction in serum creatine kinase (CK) activity compared with mdx mice fed a standard diet. Most notably, necrotic fibers in tibialis anterior (TA) muscle of mdx-Na mice were reduced by 99% and were similar in control mice. These mdx mice displayed significantly elevated blood Ca2+ and Na+ levels, while the total calcium content of their TA muscle was reduced to the level of control mice. In addition, mdx-Na mice had elevated zinc and magnesium contents in their TA muscle. These results suggest that elevated serum Na+ leads to Ca2+ extrusion from muscle via the Na+/Ca2+ exchanger causing a decrease in intracellular Ca2+ levels and an increase in blood Ca2+ levels. Extracellular Ca2+ and, in addition, Zn2+ and Mg2+ might also contribute to the stabilization of the cell membrane. Other possibilities explaining the surprisingly efficacious beneficial effect of dietary sodium exist and are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179484     DOI: 10.1152/ajpregu.00684.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  10 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

2.  Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.

Authors:  Cecilia Giulivi; Catherine Ross-Inta; Alicja Omanska-Klusek; Eleonora Napoli; Danielle Sakaguchi; Genaro Barrientos; Paul D Allen; Isaac N Pessah
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle.

Authors:  Chady H Hakim; Dongsheng Duan
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

4.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

5.  Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.

Authors:  Christopher F Spurney; Heather Gordish-Dressman; Alfredo D Guerron; Arpana Sali; Gouri S Pandey; Rashmi Rawat; Jack H Van Der Meulen; Hee-Jae Cha; Emidio E Pistilli; Terence A Partridge; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

Review 6.  Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Miranda D Grounds; Hannah G Radley; Gordon S Lynch; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  Neurobiol Dis       Date:  2008-04-09       Impact factor: 5.996

7.  New method for determining total calcium content in tissue applied to skeletal muscle with and without calsequestrin.

Authors:  Cédric R H Lamboley; Sandrine A Kake Guena; Fatou Touré; Camille Hébert; Louiza Yaddaden; Stephanie Nadeau; Patrice Bouchard; Lan Wei-LaPierre; Jean Lainé; Eric C Rousseau; Jérôme Frenette; Feliciano Protasi; Robert T Dirksen; Paul C Pape
Journal:  J Gen Physiol       Date:  2015-02       Impact factor: 4.086

8.  Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.

Authors:  Maria Laura Jorge Micheletto; Tulio de Almeida Hermes; Bruno Machado Bertassoli; Giuliana Petri; Matheus Moreira Perez; Fernando Luiz Affonso Fonseca; Alzira Alves de Siqueira Carvalho; David Feder
Journal:  Int J Exp Pathol       Date:  2020-12-09       Impact factor: 1.925

9.  The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.

Authors:  Arpana Sali; Gina M Many; Heather Gordish-Dressman; Jack H van der Meulen; Aditi Phadke; Christopher F Spurney; Avital Cnaan; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy.

Authors:  Sandrine Herbelet; Boel De Paepe; Jan L De Bleecker
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.